OVERVIEW
OUR EQUITY STORY
UCB FINANCIALS
UCB GOVERNANCE
OUR SHAREHOLDERS
ESG OVERVIEW
DOWNLOAD CENTER
NEWS
UCB STORIES
CONTACT
SETTINGS
UCB.COM
SHARE APP
Share information
211.70 €
+0.52 %
07/09/2026 11:39
Open
High
Low
Volume
210.70 €
213.70 €
209.30 €
18,069
Latest News
01-Sep-2026
UCB presents data at EEC 2026 highlighting continued leadership in epilepsy and developmental and epileptic encephalopathies
31-Aug-2026
Transparency notification Wellington Management Group LLP
31-Aug-2026
UCB Comes to Agreement with U.S. Government to Lower the Cost of Medicine and Strengthen U.S. Manufacturing
30-Jul-2026
UCB Delivers Strong Results, Raises 2026 Guidance and Positions for Next Growth Phase
Interim reports
30-Jul-2026
2026 half-year results
26-Feb-2026
2025 full-year result
31-Jul-2025
2025 half-year results
UCB Stories
30-Jul-2026
Delivering today, shaping what comes next
26-Feb-2026
Strong execution in service of patients and sustainable value
31-Jul-2025
Stronger every semester - From differentiated innovation to outstanding delivery
In Focus
30-Jul-2026 2026 Half-Year Results